Physician profile
Asha Mandava
NPI 1366538753
$490.88
in general payments reported to CMS, 2019-2025
9 companies · $289 in 2025
The $289 reported for 2025 was more than what 84% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.78 · 2022: $32.77 · 2023: $39.28 · 2024: $91.19 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $154.04 | 2025 | Azstarys |
| Sobi, INC | $86.52 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $58.47 | 2025 | |
| Cranial Technologies, INC | $46.20 | 2019-2024 | Doc Band |
| Supernus Pharmaceuticals, INC. | $40.70 | 2022-2024 | Qelbree |
| Biomarin Pharmaceutical INC. | $35.87 | 2025 | Voxzogo 1.2mg |
| Merck Sharp & Dohme LLC | $28.60 | 2023-2024 | Vaxelis, Gardasil 9, Rotateq |
| Seqirus USA INC | $24.50 | 2025 | Flucelvax |
| Lnhc, INC | $15.98 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asha Mandava listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.